Karyopharm Therapeutics Inc. Quarterly Quick Ratio in % from Q2 2020 to Q3 2024

Taxonomy & unit: ratio: %
Description: The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary: Karyopharm Therapeutics Inc. quarterly Quick Ratio history and growth rate from Q2 2020 to Q3 2024.
Karyopharm Therapeutics Inc. Quick Ratio for the quarter ending September 30, 2024 was 5.5 %, a 7.88% decline year-over-year.

Quick Ratio, Quarterly (%)

Quick Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	5.5	-0.47	-7.88%	Sep 30, 2024
Q2 2024	4.87	-1.57	-24.4%	Jun 30, 2024
Q1 2024	4.92	-1.34	-21.4%	Mar 31, 2024
Q4 2023	5.41	-0.75	-12.2%	Dec 31, 2023
Q3 2023	5.97	+0.03	+0.51%	Sep 30, 2023
Q2 2023	6.44	+0.77	+13.6%	Jun 30, 2023
Q1 2023	6.26	+0.34	+5.74%	Mar 31, 2023
Q4 2022	6.17	+0.43	+7.5%	Dec 31, 2022
Q3 2022	5.94	+0.48	+8.79%	Sep 30, 2022
Q2 2022	5.67	+0.66	+13.2%	Jun 30, 2022
Q1 2022	5.93	+1.75	+41.9%	Mar 31, 2022
Q4 2021	5.74	+2.32	+67.9%	Dec 31, 2021
Q3 2021	5.46	+2.96	+118%	Sep 30, 2021
Q2 2021	5.01	+3.36	+204%	Jun 30, 2021
Q1 2021	4.18			Mar 31, 2021
Q4 2020	3.41			Dec 31, 2020
Q3 2020	2.5			Sep 30, 2020
Q2 2020	1.65			Jun 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.